Oragenics (OGEN) EBITDA Margin (QoQ) (2010 - 2023)
Oragenics (OGEN) EBITDA Margin (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.39 Mn | 2.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -443,147.00 |
| Jun 30, 2023 | -655,859.00 |
| Sep 30, 2022 | 732,032.00 |
| Jun 30, 2022 | 1.87 Mn |
| Dec 31, 2014 | -4,307.00 |
| Sep 30, 2014 | 11,151.00 |
| Jun 30, 2014 | 14,183.00 |
| Mar 31, 2014 | -6,130.00 |
| Dec 31, 2013 | 297,364.00 |
| Sep 30, 2013 | -244,279.00 |
| Jun 30, 2013 | -25,357.00 |
| Mar 31, 2013 | -52,242.00 |
| Dec 31, 2012 | 33,167.00 |
| Sep 30, 2012 | 188,542.00 |
| Jun 30, 2012 | -229,019.00 |
| Mar 31, 2012 | 6,914.00 |
| Dec 31, 2011 | 3,062.00 |
| Sep 30, 2011 | 17,460.00 |
| Jun 30, 2011 | -22,995.00 |
| Mar 31, 2011 | 32,979.00 |